What it said it expected, against what it reported
2 targets with a reported result
Above the range
0
above the last range given
Within the range
0
of 2 range targets
Below the range
2
below the last range given
The numbers CRH said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from
| Target | What the company said | Reported | Result |
|---|---|---|---|
| EBITDA (company-defined) Fiscal 2026 |
Given $8.10B to $8.50B release 2026-07-30
Lowered $7.80B to $8.00B release 2026-10-29
|
– | No standard number |
The company's wordsReaffirming FY26 guidance for Net income ($3.9bn-$4.1bn), Adj. EBITDA* ($8.1bn-$8.5bn) and Diluted EPS ($5.60-$6.05) release 2026-07-30 Expect FY26 Net Income of $3.1B-$3.3B and Adjusted EBITDA* of $7.8B-$8.0B release 2026-10-29 | |||
| Net income Fiscal 2026 |
Given $3.90B to $4.10B release 2026-02-18
Kept $3.90B to $4.10B release 2026-04-30
Kept $3.90B to $4.10B release 2026-07-30
Lowered $3.10B to $3.30B release 2026-10-29
|
– | Not reported yet |
The company's wordsExpect further growth & value creation with FY 26 Net income of $3.9bn to $4.1bn; release 2026-02-18 Reaffirming guidance; expect FY26 Net income of $3.9bn to $4.1bn; release 2026-04-30 Reaffirming FY26 guidance for Net income ($3.9bn-$4.1bn), Adj. EBITDA* ($8.1bn-$8.5bn) and Diluted EPS ($5.60-$6.05) release 2026-07-30 Expect FY26 Net Income of $3.1B-$3.3B and Adjusted EBITDA* of $7.8B-$8.0B release 2026-10-29 | |||
| Diluted EPS Fiscal 2026 |
Given $5.60 to $6.05 release 2026-07-30
|
– | Not reported yet |
The company's wordsReaffirming FY26 guidance for Net income ($3.9bn-$4.1bn), Adj. EBITDA* ($8.1bn-$8.5bn) and Diluted EPS ($5.60-$6.05) release 2026-07-30 | |||
| Net income Fiscal 2025 (ended 2025-12-31) |
Given $3.70B to $4.10B release 2025-02-26
Kept $3.70B to $4.10B release 2025-05-05
Lowered $3.80B to $3.90B release 2025-08-06
|
$3.75B 10-K filed 2026-02-18 |
Below the range |
The company's wordsExpect FY 2025 Net income of $3.7 billion to $4.1 billion; release 2025-02-26 Reaffirming guidance; expect FY25 Net income of $3.7bn-$4.1bn; release 2025-05-05 FY25 guidance: Net income of $3.8bn-$3.9bn; release 2025-08-06 | |||
| EBITDA (company-defined) Fiscal 2024 (ended 2024-12-31) |
Given $6.55B to $6.85B release 2024-05-10
Raised $6.82B to $7.02B release 2024-08-08
Narrowed $6.87B to $6.97B release 2024-11-07
|
– | No standard number |
The company's wordsReaffirming FY24 guidance; … Adjusted EBITDA* $6.55bn to $6.85bn release 2024-05-10 Raising FY24 guidance; … Adjusted EBITDA* $6.82bn - $7.02bn release 2024-08-08 Reaffirming FY24 guidance midpoint; … Adjusted EBITDA* $6.87bn-$6.97bn release 2024-11-07 | |||
| Net income Fiscal 2024 (ended 2024-12-31) |
Given $3.55B to $3.80B release 2024-02-29
Kept $3.55B to $3.80B release 2024-05-10
Raised $3.70B to $3.85B release 2024-08-08
Raised $3.78B to $3.85B release 2024-11-07
|
$3.49B 10-K filed 2025-02-26 |
Below the range |
The company's wordsExpect FY24 Net income of $3.55bn to $3.80bn; release 2024-02-29 Reaffirming FY24 guidance; … Net income $3.55bn to $3.80bn; release 2024-05-10 Raising FY24 guidance; … Net Income $3.70bn - $3.85bn; release 2024-08-08 Reaffirming FY24 guidance midpoint; … Net Income $3.78bn-$3.85bn; release 2024-11-07 | |||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-02-29), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.